Adipose Inositol Monophosphate Metabolism Is Associated with Fasting Regimen-Elicited Metabolic Benefits
Biomolecules · 2025
DOI: 10.3390/biom15111514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Chunqing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Hauptthemen laut MEDLINE: Fasting, Adipose Tissue, White, Inositol Phosphates. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, P20 Award, American Heart Association.
Abstract (Originalsprache)
Intermittent fasting (IF) has emerged as a promising strategy for managing obesity and related metabolic disorders. Although metabolic adaptations in adipose tissue during IF are well documented, the specific reprogramming of white adipose tissue (WAT) under prolonged cycles of fasting and refeeding remains incompletely understood. Using mass spectrometry-based approaches, including liquid chromatography (LC) and capillary electrophoresis (CE), we identified a marked increase in inositol monophosphates (InsP1s) in obese adipose tissue following extended IF. Specifically, myo-inositol-1-phosphate and myo-inositol-3-phosphate, which are typically present at low levels in gonadal WAT (gWAT) of diet-induced obese mice, were significantly elevated after 15 cycles of IF. Additionally, extended IF upregulated the expression levels of inositol tetrakisphosphate 1-kinase (ITPK1) and inositol monophosphatase 1 (IMPA1), two key enzymes involved in InsP1 metabolism. These increases coincide with reductions in body weight and fat mass, as well as improved insulin sensitivity. This reprogramming was further supported by enhanced tricarboxylic acid (TCA) cycle activity. Collectively, these findings suggest the inositol monophosphate pathway as a novel mechanism underlying fasting-induced metabolic adaptation in adipose tissue and highlight the potential of these metabolites as biomarkers for obesity and related metabolic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
- Autophagy Inflammation and Metabolism Center for Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Cardiometabolic Medicine of Hunan Province, Metabolic Syndrome Research Center, The Second Xiangya Hospital of Central South University, Changs…
- The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, Hunan Normal University, Changsha 410081, China.
- Hunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, College of Life Science, Hunan Normal University, Changsha 410081, China.
ORCID-Profile: Chunqing Wang, Xing Zhang, Meilian Liu
Förderung
- NIDDK NIH HHS
- P20 Award
- American Heart Association
- R01 Awards from NIDDK
- Postdoc Fellowship Awards from American Heart Association
- Start-up research grants from Hunan Normal University
- Dedicated Health Research Funds provided by the University of New Mexico School of Medicine
Zitieren
APA
Wang, C., Liu, B., Yang, X., Chen, X., Wang, S., Zhang, X., & Liu, M. (2025). Adipose Inositol Monophosphate Metabolism Is Associated with Fasting Regimen-Elicited Metabolic Benefits. Biomolecules. https://doi.org/10.3390/biom15111514
Vancouver
Wang C, Liu B, Yang X, Chen X, Wang S, Zhang X, et al. Adipose Inositol Monophosphate Metabolism Is Associated with Fasting Regimen-Elicited Metabolic Benefits. Biomolecules. 2025. doi:10.3390/biom15111514
BibTeX
@article{Wang2025,
author = {Wang, Chunqing and Liu, Bilian and Yang, Xin and Chen, Xi and Wang, Shuo and Zhang, Xing and Liu, Meilian},
title = {Adipose Inositol Monophosphate Metabolism Is Associated with Fasting Regimen-Elicited Metabolic Benefits},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15111514}
}
EUVIMED